PACB
Pacific Biosciences of California Inc

14,426
Mkt Cap
$407.7M
Volume
6.58M
52W High
$2.73
52W Low
$0.8511
PE Ratio
-0.74
PACB Fundamentals
Price
$1.27
Prev Close
$1.35
Open
$1.30
50D MA
$1.91
Beta
2.06
Avg. Volume
6.72M
EPS (Annual)
-$1.82
P/B
76.23
Rev/Employee
$329,907.22
$983.82
Loading...
Loading...
News
all
press releases
COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook
Cooper Companies tops Q1 EPS estimates and lifts FY26 outlook as MyDay and MiSight drive growth. Shares slip despite solid margin expansion.
Zacks·6d ago
News Placeholder
More News
News Placeholder
Pacific Biosciences of California (NASDAQ:PACB) Receives Underweight Rating from Barclays
Barclays reissued an "underweight" rating and issued a $1.50 price objective on shares of Pacific Biosciences of California in a research report on Friday...
MarketBeat·6d ago
News Placeholder
Christian Henry Sells 12,497 Shares of Pacific Biosciences of California (NASDAQ:PACB) Stock
Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) insider Christian Henry sold 12,497 shares of the company's stock in a transaction that occurred on Tuesday, March 3rd. The...
MarketBeat·7d ago
News Placeholder
Clover Health Enters Collaboration to Be Part of CMS Aligned Network
CLOV jumped 8% after partnering with Kno2 to become the first payer live on a CMS Aligned Network, enabling real-time patient access to clinical and claims data.
Zacks·7d ago
News Placeholder
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
CAH shares have surged 49% in six months as strong pharma distribution, expanding specialty services and fast-growing adjacencies fuel Cardinal Health???s earnings outlook.
Zacks·7d ago
News Placeholder
Pacific Biosciences of California, Inc. $PACB Shares Sold by ARK Investment Management LLC
ARK Investment Management LLC decreased its holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 14.8% during the 3rd quarter, according to the company in its most...
MarketBeat·8d ago
News Placeholder
Pacific Biosciences of California (NASDAQ:PACB) Insider Christian Henry Sells 12,497 Shares
Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) insider Christian Henry sold 12,497 shares of the firm's stock in a transaction that occurred on Tuesday, March 3rd. The shares...
MarketBeat·8d ago
News Placeholder
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
RVTY gains from strong diagnostics demand and fast-growing Signals software, but China policy pressure and weak research spending temper near-term growth.
Zacks·8d ago
News Placeholder
Intuitive Surgical Expands Direct Operational Presence in Europe
ISRG expands in Europe after acquiring da Vinci and Ion distribution across Italy, Spain and Portugal, integrating operations to directly support customers.
Zacks·8d ago
News Placeholder
PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub
PACB teams with DNAstack to launch a global HiFi genome network, linking 10,000+ sequences to boost rare disease research without moving data.
Zacks·9d ago
<
1
2
...
>

Latest PACB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.